- Home
- GROV vs CALC Comparison
GROV vs CALC Comparison
Compare GROV & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROV
- CALC
- Stock Information
- Founded
- GROV 2016
- CALC 2011
- Country
- GROV United States
- CALC United States
- Employees
- GROV N/A
- CALC N/A
- Industry
- GROV Package Goods/Cosmetics
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- GROV Consumer Discretionary
- CALC Health Care
- Exchange
- GROV Nasdaq
- CALC Nasdaq
- Market Cap
- GROV 53.5M
- CALC 22.9M
- IPO Year
- GROV N/A
- CALC N/A
- Fundamental
- Price
- GROV $1.19
- CALC $1.61
- Analyst Decision
- GROV Hold
- CALC Strong Buy
- Analyst Count
- GROV 1
- CALC 3
- Target Price
- GROV $1.20
- CALC $16.33
- AVG Volume (30 Days)
- GROV 76.6K
- CALC 30.2K
- Earning Date
- GROV 08-07-2025
- CALC 08-11-2025
- Dividend Yield
- GROV N/A
- CALC N/A
- EPS Growth
- GROV N/A
- CALC N/A
- EPS
- GROV N/A
- CALC N/A
- Revenue
- GROV $193,427,000.00
- CALC N/A
- Revenue This Year
- GROV N/A
- CALC N/A
- Revenue Next Year
- GROV $6.22
- CALC N/A
- P/E Ratio
- GROV N/A
- CALC N/A
- Revenue Growth
- GROV N/A
- CALC N/A
- 52 Week Low
- GROV $1.02
- CALC $1.42
- 52 Week High
- GROV $1.95
- CALC $5.97
- Technical
- Relative Strength Index (RSI)
- GROV 51.35
- CALC 47.03
- Support Level
- GROV $1.10
- CALC $1.42
- Resistance Level
- GROV $1.19
- CALC $1.85
- Average True Range (ATR)
- GROV 0.07
- CALC 0.15
- MACD
- GROV 0.01
- CALC -0.00
- Stochastic Oscillator
- GROV 82.05
- CALC 44.19
About GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.